Combined Pharmacotherapies for Alcoholism (Naltrexone/Ondansetron)

Completed · Phase 2

Conditions studied: Alcoholism

In brief

This study will compare the effectiveness of ondansetron (Zofran) and naltrexone (ReVia) both alone and in combination in treating Early Onset Alcoholics versus Late Onset Alcoholics. All subjects will received standardized Cognitive Behavioral Therapy. Followup assessments will be completed at 1, 3, 6, and 9 months after treatment.

Key facts

Study ID
NCT00027079
Run by
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
People needed
360
Starts
2001-09-01
Expected to finish
2004-08-01
Last updated by the study team
2007-12-10

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.